<?xml version="1.0" encoding="UTF-8"?>
<ref id="B47">
 <label>47.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yao</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Ye</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Cui</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Niu</surname>
    <given-names>P</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [published online ahead of print, 2020 Mar 9].</article-title>
  <source>
   <italic>Clin Infect Dis.</italic>
  </source> (
  <year>2020</year>) 
  <volume>71</volume>:
  <issue>ciaa237</issue>. 
  <pub-id pub-id-type="doi">10.1093/cid/ciaa237</pub-id>
  <?supplied-pmid 32150618?>
  <pub-id pub-id-type="pmid">32150618</pub-id>
 </mixed-citation>
</ref>
